221 related articles for article (PubMed ID: 20085756)
41. Nimodipine treatment to assess a modified mouse model of intracerebral hemorrhage.
Ma B; Zhang J
Brain Res; 2006 Mar; 1078(1):182-8. PubMed ID: 16492378
[TBL] [Abstract][Full Text] [Related]
42. Feasibility, cost-effectiveness and patients' acceptance of point-of-care INR testing in a hospital-based anticoagulation clinic.
Kong MC; Lim TG; Ng HJ; Chan YH; Lee LH
Ann Hematol; 2008 Nov; 87(11):905-10. PubMed ID: 18604535
[TBL] [Abstract][Full Text] [Related]
43. Predisposing factors for enlargement of intracerebral hemorrhage in patients treated with warfarin.
Yasaka M; Minematsu K; Naritomi H; Sakata T; Yamaguchi T
Thromb Haemost; 2003 Feb; 89(2):278-83. PubMed ID: 12574807
[TBL] [Abstract][Full Text] [Related]
44. [Cerebral haemorrhage in patients treated with oral anticoagulation].
Rodríguez-Campello A; Roquer-González J; Gomis-Cortina M; Munteis-Olivas E; Ois-Santiago A; Herraiz-Rocamora J
Rev Neurol; 2005 Jan 1-15; 40(1):19-22. PubMed ID: 15696421
[TBL] [Abstract][Full Text] [Related]
45. Comparison of hematoma shape and volume estimates in warfarin versus non-warfarin-related intracerebral hemorrhage.
Sheth KN; Cushing TA; Wendell L; Lev MH; Romero JM; Schwab K; Smith EE; Greenberg SM; Rosand J; Goldstein JN
Neurocrit Care; 2010 Feb; 12(1):30-4. PubMed ID: 19859832
[TBL] [Abstract][Full Text] [Related]
46. Experimental intracerebral hemorrhage in the mouse: histological, behavioral, and hemodynamic characterization of a double-injection model.
Belayev L; Saul I; Curbelo K; Busto R; Belayev A; Zhang Y; Riyamongkol P; Zhao W; Ginsberg MD
Stroke; 2003 Sep; 34(9):2221-7. PubMed ID: 12920264
[TBL] [Abstract][Full Text] [Related]
47. Anticoagulation with the oral direct thrombin inhibitor dabigatran does not enlarge hematoma volume in experimental intracerebral hemorrhage.
Lauer A; Cianchetti FA; Van Cott EM; Schlunk F; Schulz E; Pfeilschifter W; Steinmetz H; Schaffer CB; Lo EH; Foerch C
Circulation; 2011 Oct; 124(15):1654-62. PubMed ID: 21911784
[TBL] [Abstract][Full Text] [Related]
48. Imaging of contrast medium extravasation in anticoagulation-associated intracerebral hemorrhage with dual-energy computed tomography.
Won SY; Schlunk F; Dinkel J; Karatas H; Leung W; Hayakawa K; Lauer A; Steinmetz H; Lo EH; Foerch C; Gupta R
Stroke; 2013 Oct; 44(10):2883-90. PubMed ID: 23920016
[TBL] [Abstract][Full Text] [Related]
49. Intracerebral hemorrhage in mice: model characterization and application for genetically modified mice.
Nakamura T; Xi G; Hua Y; Schallert T; Hoff JT; Keep RF
J Cereb Blood Flow Metab; 2004 May; 24(5):487-94. PubMed ID: 15129180
[TBL] [Abstract][Full Text] [Related]
50. Accuracy and clinical usefulness of the CoaguChek S and XS Point of Care devices when starting warfarin in a hospital outreach setting.
Sobieraj-Teague M; Daniel D; Farrelly B; Coghlan D; Gallus A
Thromb Res; 2009 Apr; 123(6):909-13. PubMed ID: 19042011
[TBL] [Abstract][Full Text] [Related]
51. The necessity to assess anticoagulation status in elderly injured patients.
Williams TM; Sadjadi J; Harken AH; Victorino GP
J Trauma; 2008 Oct; 65(4):772-6; discussion 776-7. PubMed ID: 18849789
[TBL] [Abstract][Full Text] [Related]
52. [Complications and risks associated with an anticoagulation therapy combining low molecular weight heparin and Warfarin after total replacement of large joints--our experience].
Míka P; Behounek J; Skoták M; Nevsímal L
Acta Chir Orthop Traumatol Cech; 2004; 71(4):237-44. PubMed ID: 15456102
[TBL] [Abstract][Full Text] [Related]
53. Decreased brain edema after collagenase-induced intracerebral hemorrhage in mice lacking the inducible nitric oxide synthase gene. Laboratory investigation.
Kim DW; Im SH; Kim JY; Kim DE; Oh GT; Jeong SW
J Neurosurg; 2009 Nov; 111(5):995-1000. PubMed ID: 19374494
[TBL] [Abstract][Full Text] [Related]
54. Tracking brain volume changes in C57BL/6J and ApoE-deficient mice in a model of neurodegeneration: a 5-week longitudinal micro-MRI study.
McDaniel B; Sheng H; Warner DS; Hedlund LW; Benveniste H
Neuroimage; 2001 Dec; 14(6):1244-55. PubMed ID: 11707081
[TBL] [Abstract][Full Text] [Related]
55. Warfarin associated intracerebral hemorrhage in Hong Kong Chinese.
Teo KC; Mahboobani NR; Lee R; Siu CW; Cheung RT; Ho SL; Lau KK; Chan KH
Neurol Res; 2014 Feb; 36(2):143-9. PubMed ID: 24172661
[TBL] [Abstract][Full Text] [Related]
56. MRI-based analysis of intracerebral hemorrhage in mice reveals relationship between hematoma expansion and the severity of symptoms.
Matsushita H; Hijioka M; Hisatsune A; Isohama Y; Iwamoto S; Terasawa H; Katsuki H
PLoS One; 2013; 8(7):e67691. PubMed ID: 23844065
[TBL] [Abstract][Full Text] [Related]
57. Anticoagulant-associated intracerebral hemorrhage.
Flaherty ML
Semin Neurol; 2010 Nov; 30(5):565-72. PubMed ID: 21207349
[TBL] [Abstract][Full Text] [Related]
58. Peri-hemorrhagic degeneration accompanies stereotaxic collagenase-mediated cortical hemorrhage in mouse.
Masuda T; Maki M; Hara K; Yasuhara T; Matsukawa N; Yu S; Bae EC; Tajiri N; Chheda SH; Solomita MA; Weinbren N; Kaneko Y; Kirov SA; Hess DC; Hida H; Borlongan CV
Brain Res; 2010 Oct; 1355():228-39. PubMed ID: 20691669
[TBL] [Abstract][Full Text] [Related]
59. Recombinant activated coagulation factor VII and prothrombin complex concentrates are equally effective in reducing hematoma volume in experimental warfarin-associated intracerebral hemorrhage.
Schlunk F; Van Cott EM; Hayakawa K; Pfeilschifter W; Lo EH; Foerch C
Stroke; 2012 Jan; 43(1):246-9. PubMed ID: 21998055
[TBL] [Abstract][Full Text] [Related]
60. Hematoma size as major modulator of the cellular immune system after experimental intracerebral hemorrhage.
Illanes S; Liesz A; Sun L; Dalpke A; Zorn M; Veltkamp R
Neurosci Lett; 2011 Mar; 490(3):170-4. PubMed ID: 21130839
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]